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Converging evidence shows that monoamine oxidase A (MAO A), the key enzyme catalyzing serotonin (5-hydroxytryptamine; 5-HT) and
norepinephrine (NE) degradation, is a primary factor in the pathophysiology of antisocial and aggressive behavior. Accordingly, male
MAO A-deficient humans and mice exhibit an extreme predisposition to aggressive outbursts in response to stress. As NMDARs regulate
the emotional reactivity to social and environmental stimuli, we hypothesized their involvement in the modulation of aggression medi-
ated by MAO A. In comparison with WT male mice, MAO A KO counterparts exhibited increases in 5-HT and NE levels across all brain
regions, but no difference in glutamate concentrations and NMDAR binding. Notably, the prefrontal cortex (PFC) of MAO A KO mice
exhibited higher expression of NR2A and NR2B, as well as lower levels of glycosylated NR1 subunits. In line with these changes, the
current amplitude and decay time of NMDARs in PFC was significantly reduced. Furthermore, the currents of these receptors were
hypersensitive to the action of the antagonists of the NMDAR complex (dizocilpine), as well as NR2A (PEAQX) and NR2B (Ro 25-6981)
subunits. Notably, systemic administration of these agents selectively countered the enhanced aggression in MAO A KO mice, at doses
that did not inherently affect motor activity. Our findings suggest that the role of MAO A in pathological aggression may be mediated by
changes in NMDAR subunit composition in the PFC, and point to a critical function of this receptor in the molecular bases of antisocial
personality.
Introduction
Antisocial and aggressive behaviors have a profound socio-
economic impact (Reiss, 1993), yet current strategies to reduce
these staggering phenomena are extremely unsatisfactory. In
particular, the clinical management of these entities remains
problematic, in view of their heterogeneous symptomatic
manifestations and the substantial limitations of available thera-
pies (Cherek et al., 2006; Harris and Lurigio, 2007). Current the-
oretical perspectives posit the existence of multiple subtypes of
pathological aggression, featuring distinct psychological profiles
and neurobiological underpinnings (Blair, 2004); in particular,
reactive aggression, the antisocial trait characterized by impulsive
and hostile responses to stressful contingencies, has been shown
to be regulated by monoamine oxidase A (MAO A), the major
enzyme catalyzing the oxidative deamination of brain serotonin
(5-hydroxytryptamine; 5-HT) and norepinephrine (NE) (Shih et
al., 1999; Bortolato et al., 2008).
The role of MAO A in reactive aggression was first highlighted
by the characterization of Brunner syndrome, a rare X-linked
condition featuring a nonsense mutation of MAOA gene, marked
increases in urinary 5-HT levels, and extreme predisposition to
violent outbursts in response to unexpected stressors (Brunner et
al., 1993). Subsequent investigations documented that male car-
riers of low-activity MAOA allelic variants had significantly
higher susceptibility to develop impulsive aggression as a long-
term sequela of early-life maltreatment and abuse (Caspi et al.,
2002; Kim-Cohen et al., 2006; Widom and Brzustowicz, 2006;
Weder et al., 2009). Finally, recent findings indicate that, in
males, the severity of antisocial traits is inversely correlated with
MAO A catalytic activity in the brain (Alia-Klein et al., 2008).
Cogent neuroimaging evidence indicates that the role of MAO
A in the pathophysiology of reactive aggression involves the fore-
brain circuits regulating social and environmental assessment
(Buckholtz and Meyer-Lindenberg, 2008); the neurochemical
bases of this phenomenon, however, remain elusive. An optimal
tool to obviate this limitation and identify novel therapeutic tar-
gets for aggression is afforded by MAO A KO mice. These mu-
tants display a spectrum of behavioral abnormalities strikingly
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isotypic with those observed in Brunner syndrome, including
highly aggressive, maladaptive, and perseverative responses to
perceived stress (Cases et al., 1995; Kim et al., 1997; Bortolato and
Shih, 2011; Godar et al., 2011). Notably, these abnormal behav-
iors are mediated by forebrain regions (Chen al, 2007).
A growing body of literature documents that the NMDARs
serve a central function in the regulation of information process-
ing (Daw et al., 1993), as well as aggressive and defensive re-
sponses (Gould and Cameron, 1997; Carobrez et al., 2001).
NMDARs are ionotropic channels formed by the combination of
different subunits, including NR1 and the four members of the
NR2 family (termed A through D) (Cull-Candy et al., 2001). NR1
is the obligatory subunit and has eight known splice variants,
resulting from the combination of three alternatively splicing
cassettes (N1, C1, and C2) in its coding region (Durand et al.,
1993). Notably, the function and subunit composition of
NMDARs are highly influenced by monoamine neurotransmit-
ters (Boyer et al., 1998; Masuko et al., 2004; Yuen et al., 2005).
This background prompted us to hypothesize that the role of
MAO A in reactive aggression may be mediated by alterations of
NMDARs. Thus, in the present study we investigated the expres-
sion and function of NMDARs in the forebrain of MAO A KO
mice, compared with their WT littermates.
Materials and Methods
Animals. We used 3- to 4-month-old, experimentally naive 129S6 adult
male mice, weighing 25–30 g. MAO A A863T KO were generated as previ-
ously described (Scott et al., 2008). Animals were housed in group cages
with ad libitum access to food and water. The room was maintained at
22°C, on a 12 h light/dark cycle. In all experiments, male MAO A KO
hemizygous mice were compared with their WT littermates. As Maoa
gene is located on the X chromosome (Lan et al., 1989), no heterozygous
or homozygous male mice are available. Animals from at least three
different litters were used, to minimize potential litter effects. Experi-
mental procedures were in compliance with the National Institutes of
Health guidelines and approved by the Animal Use Committees of the
University of Southern California and University of Cagliari.
Drugs. The NMDAR antagonist dizocilpine (MK-801; Sigma-
Aldrich), the NR2A subunit antagonist PEAQX (Tocris Bioscience), and
the NR2B subunit antagonist Ro 25-6981 (Tocris Bioscience) were dis-
solved in saline 0.9% and administered intraperitoneally in an injection
volume of 10 ml/kg.
Measurement of brain-regional 5-HT, NE, and glutamate levels by
HPLC. Neurotransmitter content was measured in the prefrontal cortex
(PFC), striatum, hippocampus, and midbrain of WT and MAO A KO
mice. Following decapitation, brain regions were rapidly dissected, fro-
zen in liquid nitrogen, and stored at 80°C. For 5-HT and NE analyses,
regions were homogenized in a solution containing 0.1 M trichloroacetic
acid, 10 mM sodium acetate, and 0.1 mM EDTA; 1 M isoproterenol was
used as an internal standard. The homogenates were sonicated and cen-
trifuged, and the supernatants were used for HPLC analysis. 5-HT and
NE were used as standards (Sigma-Aldrich). The protein concentrations
were determined using the pellet using the bicinchoninic acid kit
(Pierce), following the manufacturer’s protocol. The mobile phase was
the same as the homogenization buffer (excluding the isoproterenol)
with 7% methanol for detection of 5-HT and 5-HIAA. NE was quantified
separately using trichloroacetic acid mobile phase solution without
methanol. The mobile phases were filtered and deaerated, and the pump
speed (LC-6A liquid chromatograph, Shimadzu) was kept at 1.5 ml/min.
The reverse-phase column used was a Rexchrom S50100-ODS C18 col-
umn with a length of 25 cm and an internal diameter of 4.6 mm (Regis
Technologies). The compounds were measured at 0.7 V using an elec-
trochemical detector (L-ECD-6A, Shimadzu).
For glutamate measurement, experimental procedures were based on
previously described methods (Clarke et al., 2007). Briefly, tissues were
homogenized (1:50, w/v) by sonication in buffer solution (0.1 M citric
acid, 0.1 M sodium dihydrogen phosphate monohydrate, 5.6 mM octane
sulfonic acid, 10 M EDTA, 10% methanol (v/v), pH 2.8 with 5 M
NaOH), centrifuged at 14,000 rpm for 15 min at 4°C. The resulting
supernatant was filtered on micro-spin centrifuge tubes (0.22 m nylon
filter) and stored at 80°C until derivatized with 2,3-naphthalene dicar-
boxaldehyde (NDA, Fluka) and analyzed by HPLC. The supernatant was
diluted 1:100 in water. Diluted supernatant (40 l) was mixed with 40 l
of borate buffer (500 mM, pH 8.7), 240 l of KCN (10 mM) and 40 l of
NDA (5 mM in CH3OH); the solution was vortex-mixed and left 4 min at
room temperature for derivatization, then 15 l were injected into the
HPLC. The chromatographic system was a Waters 515 pump, an Agilent
1200 series autosampler, and a Picometrics ZetaLIF (Laser Induced Flu-
orescence) detector, equipped with a Helium/Cadmium laser (CVI
Melles-Griot) working at ex  442 nm and em  490 nm. Separation
was performed on Symmetry C18 columns (150  3.0 mm, 3.5 m,
Waters). Mobile phase was 50 mM sodium acetate (pH 5 with glacial
acetic acid) and methanol (48:52). Peaks were quantified following stan-
dard curve calibration by custom software (Millennium, Waters).
Quantitative autoradiography of [3H]dizocilpine binding sites. Animals
were anesthetized with halothane and killed by decapitation; brains were
rapidly removed, snap-frozen, and stored at 80°C until sectioning.
Coronal sections (12–16 m thick) were prepared using a cryostat at
20°C, thaw-mounted onto Superfrost Plus slides (BDH) and stored
with desiccant at 20°C until use. The following regions were analyzed:
cingulate cortex areas 3 and 1 (AP 2.2), caudate-putamen, nucleus
accumbens core and shell (AP 1.10), CA1, CA2, CA3 hippocampal
fields, dentate gyrus and basolateral amygdala (AP 1.58; AP 1.82).
Stereotaxic coordinates for each region were based on the atlas by Paxi-
nos and Franklin (2001). Adjacent sections to those used for autoradiog-
raphy were collected and stained with Neutral Red to facilitate the
identification of the selected brain areas. [ 3H]Dizocilpine binding auto-
radiography was performed as previously described (Newell et al., 2007).
Briefly, tissue slides were incubated at room temperature for 2.5 h in 30
mM HEPES buffer, pH 7.5, containing 100 M glycine, 100 M glutamate,
1 mM EDTA and 10 nM [ 3H]dizocilpine (specific activity: 27.5 Ci/mmol,
PerkinElmer). Nonspecific binding was determined in adjacent brain
sections in the presence of 20 M unlabeled ()-dizocilpine. Following
the incubation, tissue slides were rinsed twice at 4°C for 20 min each in
ice-cold HEPES buffer (30 mM, pH 7.5) containing 1 mM EDTA, dipped
in ice-cold deionized water and then air-dried. Dried tissue sections and
slide-mounted 3H-microscale standards (RPA 501 and 505, GE Health-
care Life Sciences) were placed in a BAS cassette (Fujifilm) with a BAS-
5000 imaging plate. The resulting images were analyzed with an AIDA
imaging system (Raytest), and optical densities were transformed into
levels of bound radioactivity (fmol/mg protein) with gray values gener-
ated by coexposed 3H-standards.
Immunoblotting of NMDAR subunits. Adult male MAO A KO and WT
mice (3 months old) were killed by cervical dislocation. Brains were
rapidly removed and regions of interest (PFC, hippocampus, and stria-
tum) were harvested on ice. Tissues were weighed and homogenized with
a Teflon-glass homogenizer in ice-cold 0.32 M sucrose (1:20 w/v), con-
taining 1:100 Protease Inhibitor Cocktail (Sigma-Aldrich). The homog-
enates were centrifuged (1000  g, 10 min, 4°C) to remove nuclei and
large debris (P1). The supernatants were centrifuged (20,000  g, 20 min,
4°C) to obtain crude synaptosomal fractions (P2) that were stored at
80°C until used. Each P2 was suspended (1:10, original w/v) in a solu-
tion of 7 M urea, 2 M thiourea, 4% CHAPS, 2% Ampholine, pH 3.5–10,
and 65 mM DTT. Suspensions were homogenized under mechanical stir-
ring for 2 h and then centrifuged at 14,000  g for 30 min to remove
cellular debris and insoluble materials. Protein concentrations were de-
termined using the 2D-Quant Kit (NovaBlot, GE Healthcare Life Sci-
ences). Ten micrograms of proteins were separated by SDS-PAGE using
4 –12% gradient gels, and then transferred with a semidry apparatus (GE
Healthcare Life Sciences) onto a polyvinylidene fluoride (PVDF) mem-
brane in blotting buffer (192 mM glycine, 25 mM Tris, 20% methanol, and
0.1% SDS) at 0.8 mA/cm 2 for 60 min. Membranes were rinsed in PBST
buffer (1 PBS and 0.1% Tween 20, pH 7.4). After rinsing, blots were
blocked for 1 h with 5% nonfat dry milk (NFM) in PBST and incubated
overnight at 4°C with one of the following primary antibodies: anti-
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NMDA NR1 (Cell Signaling Technology),
anti-NMDA NR1 subunit splice cassette N1
(AbD Serotec), anti-NMDA-NR1 subunit
splice cassette C2 (Millipore), anti-NMDA
NR2C (Sigma-Aldrich), anti-NMDA NR2D
(Millipore) and anti--actin (Cell Signaling
Technology), as per the manufacturer’s in-
structions. Membranes were rinsed in PBST
and incubated for 1 h with anti-Mouse and
anti-Rabbit IgG secondary antibodies (Sigma-
Aldrich) conjugated to horseradish peroxidase
(HRP) diluted at 1:15,000 in PBST-5% NFM.
For glycosylation analyses, proteins from 1-DE
were transferred to PVDF membranes and in-
cubated with 1 g/ml Concanavalin A-Biotin
(Sigma) in PBS containing 0.05% Tween 20
and 3% BSA for 1 h at RT. After incubation,
membranes were rinsed with PBS containing
0.05% Tween 20 and Concanavalin A reactivity
was revealed using streptavidin-HRP (Bio-Rad).
Immunoreactive bands were visualized by
enhanced chemiluminescence detection (Ad-
vance, GE Healthcare Life Sciences) and ac-
quired with LAS 1000 apparatus (Fujifilm). For
semiquantitative analysis of each protein, band
density in every sample was calculated using
Total lab TL120 (Nonlinear Dynamics). Data
were normalized for protein concentration us-
ing -actin as loading control. Results are rep-
resentative of three replicates on four animals
per brain area examined.
Whole-cell patch-clamp recordings. The prep-
aration of PFC slices was performed as previ-
ously described (Gonzalez-Islas and Hablitz,
2003). Briefly, male WT and MAO A KO mice
were anesthetized with halothane and killed. A
block of tissue containing PFC was rapidly dis-
sected and sliced in the coronal plane (300 m)
with a vibratome (Leica VT1000S) in ice-cold
low-Ca 2 solution containing the following
(in mM): 126 NaCl, 1.6 KCl, 1.2 NaH2PO4, 1.2
MgCl2, 0.625 CaCl2, 18 NaHCO3, and 11 glu-
cose. Slices were transferred to a holding cham-
ber with artificial CSF (ACSF, 37°C) saturated
with 95% O2 and 5% CO2 containing the fol-
lowing (in mM): 126 NaCl, 1.6 KCl, 1.2
NaH2PO4, 1.2 MgCl2, 2.4 CaCl2, 18 NaHCO3,
and 11 glucose. Slices (four per animal) were
allowed to recover for at least 1 h before being
placed in the recording chamber and super-
fused with the ACSF (37°C) saturated with
95% O2 and 5% CO2. Cells were visualized us-
ing an upright microscope with infrared illu-
mination (Axioskop FS 2 plus, Zeiss), and
whole-cell voltage-clamp recordings (one per
slice) were made by using an Axopatch 200B
amplifier (Molecular Devices). Voltage-clamp
experiments isolating NMDA-mediated EP-
SCs were performed with electrodes filled with
a solution containing the following (in mM): 20
[ 117Cs]methanesulfonic acid, HEPES, 0.4
EGTA, 2.8 NaCl, 5 TEA-Cl, 2.5 Mg2ATP, and 0.25 Mg2GTP, pH 7.2–7.4
(275–285 mOsm). Picrotoxin (100 M) and CNQX (10 M) were added
to the ACSF to block GABAA- and AMPA-mediated PSCs and to isolate
NMDA-mediated EPSCs. Experiments began after series resistance
reached stability (typically 15– 40 M). Series and input resistance were
monitored continuously on-line with a 5 mV depolarizing step (25 ms).
Data were filtered at 2 kHz, digitized at 10 kHz, and collected on-line with
acquisition software (pClamp 8.2, Molecular Devices). Layer II/III py-
ramidal neurons were identified by their pyramidal shape, presence of
a prominent apical dendrite, and the distance from the pial surface. A
bipolar stainless steel stimulating electrode (FHC) was placed 100 m
rostral to the recording electrode and was used to stimulate at a
frequency of 0.1 Hz (pulse duration 50 s). The amplitudes of
NMDA-EPSCs were calculated by taking a 30 ms window after the
peak of the EPSC and comparing this with the 5 ms window immedi-
ately before the stimulation artifact.
Figure 1. MAO A-deficient mice showed significantly higher 5-HT and NE levels in all brain regions, but similar glutamate levels
and NMDAR binding in comparison with WT mice. A, HPLC analysis revealed higher 5-HT concentrations in the PFC, striatum (STR),
hippocampus (HIP), and midbrain (MID) of MAO A KO mice. B, NE levels were also significantly greater than those in WT mice across
all brain regions tested. C, No alterations in glutamate levels were found in any brain region tested. D, Autoradiography showed no
differences in NMDAR binding in the cortical cingulate layers 1 and 3, striatal caudate-putamen, nucleus accumbens shell and core,
hippocampal cornu ammonis areas 1, 2, and 3, dentate gyrus, and basal lateral amygdala. Values are represented as mean  SEM.
*p  0.05, **p  0.01, and ***p  0.001 compared with WT mice. Cg1, Cingulate layer 1; Cg3, cingulate layer 3; CPu, caudate-
putamen; Core, nucleus accumbens core; Shell, nucleus accumbens shell; CA1, cornu ammonis area 1; CA2; CA3, cornu ammonis
area 3; DG, dentate gyrus; BLA, basolateral amygdala.
Figure 2. MAO A KO mice exhibited significant alterations in NMDA receptor subunit expression in the prefrontal cortex. A–D,
Although no alterations in NR1 or its variants were detected, MAO A-deficient animals showed significantly lower levels of
glycosylated NR1. E–H, Conversely, higher levels of NR2A and NR2B, but not NR2C or NR2D, subunit expression in the prefrontal
cortex were found in MAO A mutants compared with their WT counterparts. Values are represented as mean  SEM. *p  0.05
compared with WT mice. Con A, concanavalin A. For further details, see text.
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Locomotor activity. Locomotor behavior was tested in a familiar arena,
consisting of a Plexiglas square gray arena (40  40 cm) surrounded by 4
black walls (40 cm high). On the floor, 2 zones of equivalent areas were
defined: a central square quadrant of 28.28 cm per side, and a concentric
peripheral frame including the area within 11.72 cm from the walls. Mice
were first habituated to the apparatus for 3 consecutive days, in 5 min
testing sessions. On the fourth day, mice were treated, and placed in the
center of the arena after 30 min. Locomotor behavior was monitored for
5 min. Light and background noise in the room were kept at 10 lux and 70
dB respectively. Locomotor tracking was performed with Ethovision
software (Noldus).
Resident-intruder test. Testing was performed as previously indicated
(Bortolato et al., 2011). Male mice were isolated for 14 d in their home
cages before testing. The choice of this duration was based on previous
studies in our laboratory, which have assessed that this regimen is suffi-
cient to evoke robust reactive aggressive responses in 129S6 MAO A KO
mice, but not WT littermates (Bortolato et al., 2011). Following isolation,
resident mice were habituated to the experimental room for 30 min. Light
and sound were maintained at 10 lux and 70 dB, respectively. Mice were
exposed to age- and weight-matched WT males (previously acclimated to
the same room) from different litters, for 5 min. Behavior was video-
monitored from an adjacent room, recorded and scored by trained observers
unaware of the genotype. Measures included: (1) attack latency, (2) attack
duration (total), (3) number of aggressive bouts, and (4) total locomotor
activity, measured as number of crossings on a grid superimposed onto the
image of each cage in the video monitor.
Statistical analyses. Normality and homosce-
dasticity of data distribution were verified us-
ing the Kolmogorov–Smirnov and Bartlett’s
test. Parametric analyses were performed with
one-way or two-way ANOVA, as appropriate,
followed by Tukey’s test with Spjøtvoll-Stoline
correction for post hoc comparisons. Nonpara-
metric comparisons were performed by
Kruskal–Wallis test, with Nemenyi’s test for
post hoc comparisons. Significance threshold
was set at p  0.05.
Results
Brain-regional 5-HT, NE, and
glutamate levels
As expected, 5-HT and NE content was
increased throughout all brain regions of
MAO A KO mice (Fig. 1A,B), including
the PFC (5-HT: F(1,9)  25.91; p  0.001;
NE: F(1,9)  23.19; p  0.001), striatum
(5-HT: F(1,8)  7.36; p  0.05; NE: F(1,8) 
13.95; p  0.01), hippocampus (5-HT:
F(1,9)  7.00; p  0.05; NE: F(1,9)  15.35;
p  0.01) and midbrain (5-HT: F(1,9) 
12.32; p  0.01; NE: F(1,8)  63.57; p 
0.001). Conversely, the analysis of gluta-
mate content across the same brain re-
gions of WT and MAO A KO mice
revealed no significant differences be-
tween genotypes (Fig. 1C).
[ 3H]Dizocilpine binding sites
Autoradiographic analyses revealed no
differences in [ 3H]dizocilpine binding
between WT and MAO A KO mice across any tested forebrain
region, including PFC (Cg1 and Cg3), dorsal striatum (CPu),
nucleus accumbens (Shell and Core), hippocampus (CA1, CA2,
CA3, DG) and basolateral amygdala (Fig. 1D).
Immunoblotting of NMDA subunits
We then examined the expression of NMDAR subunits NR1,
NR2A, and NR2B in brain-regional synaptosomes of MAO A KO
and WT mice. In the PFC (Fig. 2), no differences were found in
NR1 total expression (NR1-Pan) (Fig. 2A) or in the levels of its
splice variants n1 (Fig. 2B) and c2 (Fig. 2C). Nevertheless, immu-
noblotting with the mannose-associating lectin concanavalin A
revealed a significantly lower glycosylation level in the NR1 sub-
units of MAO A mutants (F(1,6)  6.68; p  0.05) (Fig. 2D). In
contrast, MAO A KO mice displayed significantly higher expres-
sions of NR2A (Fig. 2E) (F(1,6)  6.56; p  0.05) and NR2B (Fig.
2F) (F(1,6)  9.50; p  0.05), but not NR2C (Fig. 2G) or NR2D
(Fig. 2H). No significant differences in either the glycosylation of
NR2 subunits or NR2A:NR2B ratio (WT: 1.12  0.08; MAO A
KO: 1.50  0.13, p  0.10) were found. The expression of
NMDAR subunits in the striatum or hippocampus was compa-
rable between the two genotypes (Table 1).
Figure 3. MAO A-deficient mice exhibited marked alterations in electrophysiological properties of NMDARs in the prefrontal
cortex. A–C, In comparison to their WT counterparts, MAO A KO mice displayed a reduction in EPSC decay time and amplitude of
NMDA EPSCs, but no changes in minimum stimulus intensity. D–F, MAO-A KO mice showed a greater decrease in percent NMDA
EPSCs than WT mice following treatment with the NMDA receptor antagonist dizocilpine, the NR2A subunit-specific inhibitor
PEAQX, and the NR2B subunit blocker Ro 25-6981. Values are represented as mean  SEM. *p  0.05, **p  0.01, and ***p 
0.001 compared to WT mice. Open/white circles, WT; closed/colored circles, MAO A KO.
Table 1. Normalized expression of NMDA subunits in striatum and hippocampus
NR1-pan NR2A NR2B
WT MAO A KO WT MAO A KO WT MAO A KO
Striatum 2.46  1.54 2.86  1.56 3.09  1.27 2.27  0.86 2.16  0.94 3.61  0.79
Hippocampus 1.99  0.63 2.89  0.78 2.85  1.01 3.02  1.26 3.78  0.83 3.52  0.62
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Ex vivo electrophysiology
As the biophysical and pharmacological properties of NMDAR
are known to reflect differences in its subunit composition
(Monyer et al., 1994; Mori and Mishina, 1995; Cull-Candy et al.,
2001), the finding of higher expression of NR2A and NR2B sub-
units in the PFC of MAO A KO mice prompted us to study the
characteristics of NMDAR-mediated currents in this region. In
comparison with their WT controls, MAO A KO mice showed a
highly significant reduction in the decay time of EPSCs (Fig. 3A)
(F(1,33)  15.39; p  0.001). While the minimum stimulus inten-
sities were equivalent between the two genotypes (Fig. 3B) (F(1,34) 
0.19; NS), EPSC amplitudes were significantly lower in MAO A
KO mice (Fig. 3C) in correspondence of the range of stimulus
intensities between 0.08 nA and 0.8 nA [p  0.05 at 0.08 nA; p 
0.01 at 0.09 and 0.1 nA; p  0.05 at 0.2– 0.8 nA]. Following the
measurement of the physiological differences of NMDARs be-
tween the two genotypes, we studied the responses of these targets
to their antagonists. Administration of dizocilpine produced a
significant reduction in the percentage of NMDA EPSCs in MAO
A KO mice at all tested doses (Fig. 3D) [p  0.05 at 30 and 100 nM;
p  0.01 at 300 nM]. The NR2A-specific antagonist PEAQX de-
creased NMDA EPSCs in MAO A KO mice; this effect was par-
ticularly evident at the lowest dose of PEAQX (Fig. 3E) [p  0.05
at 5 nM; p  0.10 at 500 nM]. Finally, the NR2B subunit-specific
antagonist Ro 25– 6981 elicited a significant reduction in NMDA
EPSCs at all doses tested (Fig. 3F) (p  0.01 at 5 nM; p  0.001 at
50 nM; p  0.05 at 500 nM).
Locomotor activity
To explore the behavioral impact of altered NMDAR function,
we evaluated the locomotor responses of selective antagonists on
NMDARs containing NR2A and NR2B subunits in MAO A KO
mice. We first examined the behavior of WT and MAO A KO
mice to the NMDAR antagonist dizocilpine (0.1 mg/kg, i.p.).
As expected, saline-treated MAO A KO mice exhibited a re-
duction in locomotor activity, albeit not significant. Dizocil-
pine elicited a significant increment of locomotor activity in
WT mice (Fig. 4 B) (genotype  time: F(1,36)  6.49; p  0.05;
p  0.05 for WT-DIZ vs WT-SAL), but not in MAO A KO
mutants. The higher dose of dizocilpine (0.3 mg/kg, i.p.) in-
duced severe ataxia and stereotyped behavior in MAO A KO
mice, but not in WT littermates (data not shown). Adminis-
tration of the NR2A antagonist PEAQX (2 mg/kg, i.p.) or the
NR2B subunit antagonist Ro 25– 6981 (5 mg/kg, i.p.) failed to
significantly alter locomotor activity (Fig. 4 B, C) (NR2A:
F(1,29)  0.52; NS and NR2B: F(1,31)  0.08; NS).
Resident-intruder aggression assay
After the assessment of the locomotor responses of WT and MAO A
KO mice to NMDAR antagonists, we proceeded to measure the
impact of these drugs on the resident-intruder aggression paradigm.
Dizocilpine (0.1 mg/kg, i.p.) elicited marked anti-aggressive
effects on MAO A KO mice, as revealed by the significant in-
creases in their latency to fight, which was normalized to the
levels observed in WT animals (Fig. 5A) (H(3,40)  19.69; p 
0.001; p  0.001 for KO-SAL vs WT-SAL and KO-DIZ vs KO-
SAL); this agent also reduced the number of fighting episodes in
MAO A KO mice (Fig. 5B) (genotype  treatment: F(1,37) 
14.44; p  0.001; p  0.001 for KO-SAL vs WT-SAL and KO-DIZ
vs KO-SAL) and overall fighting duration (Fig. 5C) (genotype 
treatment: F(1,37)  16.88; p  0.001; p  0.001 for KO-SAL vs
WT-SAL and KO-DIZ vs KO-SAL). In partial agreement with
our previous results in the open field, the drug did not induce any
significant change in locomotor activity in either genotype (data
not shown).
Both PEAQX (2 mg/kg, i.p.) and Ro 25– 6981 (5 mg/kg, i.p.)
also elicited a profound reduction of aggressive behaviors, with
significant increases in the latencies to the first fighting approach
(Fig. 5D,G) (NR2A: H(3,38)  18.46; p  0.001 and NR2B:
H(3,40)  21.54; p  0.001), number of fighting episodes (Fig.
5E,H) (NR2A: F(1,35)  6.08; p  0.05 and NR2B: F(1,37)  11.65;
p  0.01), and overall duration of fighting (Fig. 5F, I) (NR2A:
F(1,35)  9.56; p  0.01 and NR2B: F(1,37)  10.57; p  0.01). Post
hoc analyses confirmed that saline-treated MAO A KO mice dis-
played a significantly shorter latency to fight (NR2A: p  0.001
and NR2B: p  0.001), higher number of fighting bouts (NR2A:
p  0.001 and NR2B: p  0.001) and longer fighting duration
(NR2A: p  0.001 and NR2B: p  0.001) than their WT counter-
parts. Moreover, PEAQX and Ro 25– 6981 administration signif-
icantly increased the latency to fight (NR2A: p  0.01 and NR2B:
p  0.001) and decreased fighting frequency (NR2A: p  0.001
and NR2B: p  0.001) and duration (NR2A: p  0.001 and
NR2B: p  0.001) in MAO A KO mice.
Discussion
We showed that the PFC of MAO A-deficient mice exhibited
significant variations of synaptic expression of NMDAR sub-
units, including increases in NR2A and NR2B and marked defi-
cits in N-glycosylated NR1. These imbalances led to overt
abnormalities of NMDAR properties, including marked reduc-
tions of decay time and excitability, as well as hypersensitivity to
dizocilpine and selective NR2A and NR2B blockers. Notably, sys-
Figure 4. Dizocilpine altered locomotor activity in WT, but not in MAO A mutant mice. A,
Dizocilpine elicited a significant increase in total distance traveled by WT mice. B, C, Both NR2A
and NR2B subunit antagonism showed comparable effects in both genotypes in all parameters
tested. Values are represented as mean  SEM. *p  0.05 compared with WT mice treated
with saline.
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temic administration of these agents to MAO A KO mice reduced
aggression to a degree comparable to those observed in WT lit-
termates, without affecting locomotor activity.
These findings collectively suggest that MAO A modulates
aggressive behaviors by controlling the structure and function of
synaptic NMDARs in the PFC. Cogent evidence documents that
PFC is a key player in the modulation of aggression and allows for
the emotional appraisal of socio-affective and environmental
stimuli and the initiation of appropriate behavioral responses
(Davidson, 2002; Phillips et al., 2003; Ochsner and Gross, 2005).
Pyramidal neurons in the PFC integrate multiple synaptic signals
from different brain areas, and project to main components of the
limbic-subcortical circuit that regulate negative affect and reactive
aggression, such as the amygdaloid nuclei, medial hypothalamus
and dorsal periaqueductal gray (Panksepp, 1998; Gregg and Sie-
gel, 2001). The NMDAR works as a “coincidence detector” that en-
ables the spatial and temporal summation of converging inputs
(Seeburg et al., 1995). This mechanism plays a pivotal role in the
dynamic coordination of information processing, insofar as it allows
for the amplification of contextually pertinent signals and the sup-
pression of irrelevant stimuli (Phillips et al., 2010). Furthermore,
NMDARs are instrumental for the activation of PFC pyramidal neu-
rons (Shi and Zhang, 2003; Jackson et al., 2004), as well as their
interactions with interneurons (Homayoun and Moghaddam,
2007). Thus, the observed reductions in decay time and excitability
in prefrontal NMDARs are likely to decrease the temporal integra-
tion of nonsynchronous synaptic inputs, and impair the ability of
pyramidal neurons to regulate emotional processing of social and
environmental stimuli (Rolls et al., 2008). The involvement of pre-
frontal NMDARs in the link between MAO A and the vulnerability
to reactive aggression complements previous reports docu-
menting PFC alterations in male carriers of low-activity MAOA
allelic variants (Meyer-Lindenberg et al.,
2006; Lee and Ham, 2008). These pertur-
bations are conducive to a negative bias in
the emotional appraisal of ambiguous
socio-affective and contextual cues (Pas-
samonti et al., 2006; Eisenberger et al.,
2007; Brummett et al., 2008; Lee and
Ham, 2008; McDermott et al., 2009),
thereby enhancing the predisposition to
reactive aggression in response to adverse
experiences, particularly during early de-
velopmental stages (Buckholtz and Meyer-
Lindenberg, 2008). Notably, MAO A KO
mice exhibit alterations in risk assessment
and paradoxical defensive reactivity to neu-
tral and predator cues (Bortolato and Shih,
2011; Godar et al., 2011).
The increments in synaptic NR2A and
NR2B in the PFC of MAO A-deficient
mice were not paralleled by changes in the
total levels of NR1 (or its splice cassettes),
NR2C or NR2D, but rather by a marked
reduction of NR1 N-glycosylation, as re-
vealed by immunoblotting with the
mannose-associating lectin concanavalin
A. N-Glycosylation processes occur at the
membrane of the endoplasmic reticulum
and require the activation of a poorly de-
fined set of glycosyltransferase complexes
(Ivatt, 1981; Kornfeld and Kornfeld, 1985;
Burda and Aebi, 1999). The observed al-
terations may result from functional impairments of this enzy-
matic machinery; accordingly, previous studies showed that, in
cortical neurons, the inhibition of the first enzymatic step of
N-glycosylation enhances the degradation of nonglycosylated
NR1, but not NR2A subunits (Gascón et al., 2007). The extensive
N-glycosylation of NR1 (based on the attachment of high-
mannose oligosaccharide side-chains onto 12 Asparagine sites) is
essential for its oligomerization with NR2 subunits (Chazot et al.,
1995; Standley and Baudry, 2000); thus, the increased expression
in NR2A and NR2B may be paralleled by a reduced number
of functional NR1 subunits. These variations leave the total
NMDAR number unaffected (as confirmed by our dizocilpine
binding analyses), but lead to pronounced alterations of the stoi-
chiometric relations among subunits within each channel.
Changes in NR2A and NR2B subunit composition provide dif-
ferential contributions to the temporal dynamics and conductance
of the NMDA channel, as well as its modulatory role on synaptic
plasticity mechanisms (Liu et al., 2004; Massey et al., 2004; Foster et
al., 2010). Therefore, our observations may reflect the combined
increments of both NR2A and NR2B subunits. Indeed, increases in
NR2A subunits are linked to accelerated NMDA current kinetics
(Carmignoto and Vicini, 1992; Flint et al., 1997; Vicini et al., 1998),
whereas increments in NR2B subunits may affect the amplitude of
NMDAR currents (Vicini et al., 1998). Since NR2A and NR2B reg-
ulate dendritic length and size (Ewald et al., 2008; Sepulveda et al.,
2010), their increased expression may also partially account for the
changes in dendritic arborization in PFC pyramidal neurons of
MAO A-deficient mice (Bortolato et al., 2011).
The neurochemical underpinnings of the reduction in
N-glycosylated NR1 and increase in NR2A and NR2B subunits in
the PFC remain unknown. MAO A is a critical regulator of the
homeostatic balance of 5-HT and NE in the brain, and its defi-
Figure 5. Dizocilpine, PEAQX, and Ro 25-6981 significantly decreased aggression in MAO A-deficient mice. A–C, NMDAR
antagonism elicited a significant increase in latency to fight, as well as reduced the fighting frequency and duration in MAO A KO
mice. D–F, Similarly, MAO A mutants displayed an increase in latency to fight and engaged in lower fighting bouts and duration
following NR2A subunit antagonism. G–I, NR2B inhibition significantly elevated the latency, and decreased the bouts and overall
duration of fighting behavior in MAO A KO mice. Values represented as mean  SEM. ***p  0.001 compared with saline-treated
WT mice; ##p  0.01 and ###p  0.001 compared with MAO A KO mice treated with saline.
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ciency results in marked perturbations in the signaling of these
monoamines (Shih et al., 1999; Bortolato and Shih, 2011). Al-
though the observed changes in NR1 glycosylation and NMDAR
subunit expression may be underpinned by increases in 5-HT
and/or NE levels, this possibility is tempered by the observation
that the changes in NMDARs were only found in the PFC, in
contrast with the ubiquitous enhancements in monoamine con-
centrations across all brain areas. The regional selectivity of the
structural variations of NMDARs may instead reflect the activa-
tion of 5-HT or NE receptors which are particularly abundant in
prefrontal pyramidal neurons, such as 5-HT1A or 5-HT2A. Ac-
cordingly, activation of 5-HT1A receptors has been found to
modulate the expression of NMDAR subunits in these cells (Yuen
et al., 2005). Further studies will be needed to evaluate the neu-
rodevelopmental role of NE and other neurochemical targets in
the structural, biophysical and pharmacological properties of
NMDARs in MAO A KO mice.
Alterations in NR2A and NR2B subunit expression patterns
have been linked to neurodevelopmental changes (Monyer et al.,
1994; Sheng et al., 1994; Zhong et al., 1995; Portera-Cailliau et al.,
1996; van Zundert et al., 2004), which may play relevant roles in
the modulation of corticogenesis (Barth and Malenka, 2001;
Philpot et al., 2001; Fagiolini et al., 2003; Yoshimura et al., 2003).
In rodents, the cortical distribution of NR2B is very abundant
throughout prenatal and early postnatal stages, but tends to de-
crease after the first postnatal week; conversely, NR2A expression
is barely detectable at birth, but increases with age (Monyer et al.,
1994; Mori and Mishina, 1995). The behavioral deficits of MAO
A KO mice are likely supported by early neurodevelopmental
processes; for example, normalization of 5-HT brain levels dur-
ing the first weeks of postnatal life rescues several phenotypic
alterations in MAO A KO mice (Cases et al., 1995). Building on
these premises, it may be hypothesized that early alterations in
monoaminergic neurotransmission in male MAO A-deficient
subjects may be conducive to persistent alterations in NMDA
subunit expression, which may in turn disrupt PFC connectivity
and increase aggression vulnerability.
The alterations in NR2A and NR2B expression also affected
the pharmacological responses of prefrontal NMDARs. In line
with previous evidence (Mori and Mishina, 1995), the increased
NR2A and NR2B distribution induced hypersensitivity to
NMDAR antagonists. Administration of these agents signifi-
cantly reduced resident-intruder aggression in MAO A KO mice,
as signified by the marked decrease in overall duration and num-
ber of fighting episodes, as well as by the significant increase in
latency to the first attack. These changes were not accompanied
by variations in locomotor activity in MAO A KO mice, suggest-
ing a specific anti-aggressive effect of NMDAR antagonists. Nev-
ertheless, given that our behavioral analyses were only limited to
the measurement of impulsive aggressive responses in MAO A
KO mice, we cannot exclude that the observed actions of
NMDAR antagonists may reflect other underlying emotional
alterations.
The available preclinical evidence indicates that NMDAR an-
tagonists yield highly variable effects in experimental models of
aggression; in fact, whereas these agents increase fighting re-
sponses in rodents with low proclivity to aggression, they yield
the opposite effects in aggressive counterparts (Miczek and Fish,
2006). These apparent discrepancies may reflect the inability of
most rodent paradigms to distinguish between reactive and in-
strumental aggression (Nelson and Trainor, 2007); in this per-
spective, it is worth noting that the striking isomorphism of the
endophenotypes of MAO A-deficient mice with the behavioral
repertoire of impulsive antisocial manifestations in humans suggest
a high predictive validity of these models for the development of
anti-aggressive agents. The high translational relevance of our results
points to low-dose NMDAR antagonists (or selective NR2A and
NR2B blockers) as valuable therapeutic options for reactive aggres-
sion. Accordingly, recent studies have highlighted the potential of
low-dose or low-potency NMDA antagonists as efficacious anti-
aggressive treatments in several neuropsychiatric disorders (Bachen-
berg, 1998; Wilcock et al., 2008; Ballard et al., 2009).
In summary, the present findings highlight NMDARs as
promising targets in the treatment of antisocial aggressive traits
in individuals with low MAO A activity. Future clinical studies
are warranted to validate this intriguing possibility and fully es-
tablish the anti-aggressive properties of NMDAR blockers.
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